Preventing contrast-induced nephropathy in patients undergoing primary PCI

Journal of Invasive Cardiology

Volumn 23, Issue 11, 2011, Pages 451-452

  Hogan, Shea ^a   Gurm, Hitinder S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE DERIVATIVE; CALCINEURIN INHIBITOR; CONTRAST MEDIUM; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANGIOCARDIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE CLEARANCE; DRUG CHOICE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; HYDRATION; NOTE; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MYOCARDIAL INFARCTION;

EID: 80655125459     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44(9):1780-1785. (Pubitemid 39424075)
2. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259-2264. (Pubitemid 34535335)
3. Chong E, Poh KK, Liang S, et al. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol. 2010;23(5):451-459.
4. Kanei Y, Ayabe K, Ratcliffe J, et al. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Invasive Cardiol. 2011;23(11):448-450.
5. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491-499. (Pubitemid 36159884)
6. Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2009;2(7):645-654.
7. Reed MC, Moscucci M, Smith DE, et al. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Invasive Cardiol. 2010; 22(10), 467-472.
8. Thiele H, Hildebrand L, Schirdewahn C, et al. Impact of high-dose N-acetylcys-teine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate Percutaneous Coronary Intervention Acute Myocardial Infarction N-ACC) trial. J Am Coll Cardiol. 2010;55(20):2201-2209.
9. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill W W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103(5):368-375. (Pubitemid 27506242)
10. Freeman RV, O'Donnell M, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90(10):1068-1073. (Pubitemid 35335595)
11. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-1399. (Pubitemid 39303939)
12. Gurm HS, Dixon SR, Smith DE, et al. Renal function-based contrast dosing to defne safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011;58(9):907-914.